Skip to main content
Top
Published in: Infection 6/2020

01-12-2020 | Echocardiography | Original Paper

Myocarditis in admitted patients with dengue fever

Authors: M. Bhatt, M. Soneja, F. A. Farooqui, P. Singla, N. K. Vikram, A. Biswas, A. Roy, N. Wig

Published in: Infection | Issue 6/2020

Login to get access

Abstract

Purpose

Cardiac involvement in dengue fever is underdiagnosed due to low index of clinical suspicion and its contribution to hemodynamic instability in severe dengue is not well known.

Methods

A prospective observational study was conducted among admitted patients ≥ 14 years of age having confirmed dengue fever. Patients on medications affecting heart rhythm/rate, pre-existing heart disease and electrolyte abnormalities were excluded. A baseline electrocardiography (ECG), Trop-I and NT-proBNP were done for all patients. The biomarkers were measured using enzyme-linked fluorescent assay and recommended cut-off were used. Patients with elevated biomarkers underwent 2-dimensional echocardiography. Diagnosis of myocarditis was as per European Society of Cardiology (ESC) 2013 criteria.

Results

A total of 182 patients were recruited with mean age of 30 ± 12.6 years and 31% were females. Dengue with warning signs was present in 85 (47%) and severe dengue in 60 (33%) patients. ECG abnormalities were observed in 44 (24%) patients, biomarkers were elevated in 27 (15%) patients and 11 (6%) patients had echocardiographic abnormalities. According to ESC 2013 criteria, dengue fever with myocarditis was diagnosed in 13 [7.1% (95% CI 3.4–10.9)] patients. The patients with myocarditis were more likely to have shortness of breath, bleeding manifestations and higher respiratory rate at baseline. Clinical features of fluid overload were more common (69% vs. 1.7%, p < 0.01) and the duration of hospital stay longer in myocarditis group (7 ± 4.3 vs. 4.8 ± 1.9 days, p < 0.01).

Conclusion

Myocarditis among admitted dengue patients is not uncommon and may lead to increased morbidity.
Literature
1.
go back to reference Gibbons RV, Vaughn DW. Clinical review dengue: an escalating problem. BMJ. 2002;324:1563–6.CrossRef Gibbons RV, Vaughn DW. Clinical review dengue: an escalating problem. BMJ. 2002;324:1563–6.CrossRef
2.
go back to reference Agarwal R, Kapoor S, Nagar R, Misra A, Tandon R, Mathur A, et al. A clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. Southeast Asian J Trop Med Public Health. 1999;30:735–40.PubMed Agarwal R, Kapoor S, Nagar R, Misra A, Tandon R, Mathur A, et al. A clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. Southeast Asian J Trop Med Public Health. 1999;30:735–40.PubMed
4.
go back to reference Satarasinghe RL, Arultnithy K, Amerasena NL, Bulugahapitiya U, Sahayam DV. Asymptomatic myocardial involvement in acute dengue virus infection in a cohort of adult Sri Lankans admitted to a tertiary referral centre. Br J Cardiol. 2007;14:171–3. Satarasinghe RL, Arultnithy K, Amerasena NL, Bulugahapitiya U, Sahayam DV. Asymptomatic myocardial involvement in acute dengue virus infection in a cohort of adult Sri Lankans admitted to a tertiary referral centre. Br J Cardiol. 2007;14:171–3.
5.
go back to reference Veloso HH, Ferreira JA, Paiva JM, Honorio JF, Bellei NC, Paola AA. Acute atrial fibrillation during dengue hemorrhagic fever. Braz J Infect Dis. 2003;7:418–22.CrossRef Veloso HH, Ferreira JA, Paiva JM, Honorio JF, Bellei NC, Paola AA. Acute atrial fibrillation during dengue hemorrhagic fever. Braz J Infect Dis. 2003;7:418–22.CrossRef
6.
go back to reference Promphan W, Sopontammarak S, Pruekprasert P, Kajornwattanakul W, Kongpattanayothin A. Dengue myocarditis. Southeast Asian J Trop Med Public Health. 2004;35:611–3.PubMed Promphan W, Sopontammarak S, Pruekprasert P, Kajornwattanakul W, Kongpattanayothin A. Dengue myocarditis. Southeast Asian J Trop Med Public Health. 2004;35:611–3.PubMed
7.
go back to reference Kularatne SAM, Pathirage MMK, Kumarasiri PVR, Gunasena S, Mahindawanse SI. Cardiac complications of a dengue fever outbreak in Sri Lanka, 2005. Trans R Soc Trop Med Hyg. 2007;101:804–8.CrossRef Kularatne SAM, Pathirage MMK, Kumarasiri PVR, Gunasena S, Mahindawanse SI. Cardiac complications of a dengue fever outbreak in Sri Lanka, 2005. Trans R Soc Trop Med Hyg. 2007;101:804–8.CrossRef
8.
go back to reference Khongphatthallayothin A, Chotivitayatarakorn P, Somchit S, Mitprasart A, Sakolsattayadorn S, Thisyakorn C. Morbitz type I second degree AV block during recovery from dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 2000;31:642–5.PubMed Khongphatthallayothin A, Chotivitayatarakorn P, Somchit S, Mitprasart A, Sakolsattayadorn S, Thisyakorn C. Morbitz type I second degree AV block during recovery from dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 2000;31:642–5.PubMed
9.
go back to reference Li Y, Hu Z, Huang Y, Li J, Hong W, Qin Z, et al. Characterization of the Myocarditis during the worst outbreak of dengue infection in China. Medicine (Baltimore). 2016;95:e4051.CrossRef Li Y, Hu Z, Huang Y, Li J, Hong W, Qin Z, et al. Characterization of the Myocarditis during the worst outbreak of dengue infection in China. Medicine (Baltimore). 2016;95:e4051.CrossRef
10.
go back to reference Miranda CH, Borges MDC, Matsuno AK, Vilar FC, Gali LG, Volpe GJ, et al. Evaluation of cardiac involvement during dengue viral infection. Clin Infect Dis. 2013;57:812–9.CrossRef Miranda CH, Borges MDC, Matsuno AK, Vilar FC, Gali LG, Volpe GJ, et al. Evaluation of cardiac involvement during dengue viral infection. Clin Infect Dis. 2013;57:812–9.CrossRef
11.
go back to reference Arora M, Patil RS. Cardiac manifestation in dengue fever. J Assoc Phys India. 2016;64:40–4. Arora M, Patil RS. Cardiac manifestation in dengue fever. J Assoc Phys India. 2016;64:40–4.
12.
go back to reference Sheetal S, Jacob E. A study on the cardiac manifestations of dengue. J Assoc Phys India. 2016;64:30–4. Sheetal S, Jacob E. A study on the cardiac manifestations of dengue. J Assoc Phys India. 2016;64:30–4.
13.
go back to reference Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636–48.CrossRef Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636–48.CrossRef
14.
go back to reference Khongphatthanayothin A, Lertsapcharoen P, Supachokchaiwattana P, La-orkhun V, Khumtonvong A, Boonlarptaveechoke C, et al. Myocardial depression in dengue hemorrhagic fever: prevalence and clinical description. Pediatr Crit Care Med. 2007;8:524–9.CrossRef Khongphatthanayothin A, Lertsapcharoen P, Supachokchaiwattana P, La-orkhun V, Khumtonvong A, Boonlarptaveechoke C, et al. Myocardial depression in dengue hemorrhagic fever: prevalence and clinical description. Pediatr Crit Care Med. 2007;8:524–9.CrossRef
15.
go back to reference Lakshman A, Balasubramanian P, Nampoothiri RV, Vijayvergiya R, Bhalla A, Varma SC. Elevated cardiac biomarkers and echocardiographic left ventricular dysfunction at admission in patients with dengue fever: report from a tertiary care center in Northwest India. Trop Doct. 2018;48:261–5.CrossRef Lakshman A, Balasubramanian P, Nampoothiri RV, Vijayvergiya R, Bhalla A, Varma SC. Elevated cardiac biomarkers and echocardiographic left ventricular dysfunction at admission in patients with dengue fever: report from a tertiary care center in Northwest India. Trop Doct. 2018;48:261–5.CrossRef
16.
go back to reference Datta G, Mitra P. A study on cardiac manifestations of dengue fever. J Assoc Phys India. 2019;67:14–6. Datta G, Mitra P. A study on cardiac manifestations of dengue fever. J Assoc Phys India. 2019;67:14–6.
17.
go back to reference Wali JP, Biswas A, Chandra S, Malhotra A, Aggarwal P, Handa R, et al. Cardiac involvement in dengue haemorrhagic fever. Int J Cardiol. 1998;64:31–6.CrossRef Wali JP, Biswas A, Chandra S, Malhotra A, Aggarwal P, Handa R, et al. Cardiac involvement in dengue haemorrhagic fever. Int J Cardiol. 1998;64:31–6.CrossRef
18.
go back to reference Halstead S, Wilder-Smith A. Severe dengue in travellers: pathogenesis, risk and clinical management. J Travel Med. 2019;26:taz062.CrossRef Halstead S, Wilder-Smith A. Severe dengue in travellers: pathogenesis, risk and clinical management. J Travel Med. 2019;26:taz062.CrossRef
19.
go back to reference Salgado DM, Eltit JM, Mansfield K, Panqueba C, Castro D, Vega MR, et al. Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J. 2010;29:238–42.CrossRef Salgado DM, Eltit JM, Mansfield K, Panqueba C, Castro D, Vega MR, et al. Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J. 2010;29:238–42.CrossRef
Metadata
Title
Myocarditis in admitted patients with dengue fever
Authors
M. Bhatt
M. Soneja
F. A. Farooqui
P. Singla
N. K. Vikram
A. Biswas
A. Roy
N. Wig
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-020-01500-w

Other articles of this Issue 6/2020

Infection 6/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.